Fintel reports that on October 29, 2025, Guggenheim maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) with a ...

Fintel reports that on October 29, 2025, Cantor Fitzgerald maintained coverage of Regeneron Pharmaceuticals (NasdaqGS:REGN) ...

The bear phase in Regeneron (REGN) appears over. Shares bottomed at around $550 - $575 and jumped by around 12% to over $650 ...

Until recently, GLP -1s, a powerful new class of weight-loss drugs, were confined mostly to rich countries. Yet the World ...

Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its ...

POP MART’s stock slumped after a JPMorgan downgrade, erasing billions in value This is linked to a narrowing premium for Labubu dolls in secondary markets The company plans a new animation and toys to ...

Major indices opened higher on Tuesday as market participants digested some solid quarterly earnings reports at the bell.

At the close, the Dow Jones Industrial Average was up 0.34% at 47,706.37, while the S&P 500 advanced 0.23% to 6,890.89, and ...